Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc AGRX

Alternate Symbol(s):  AGXRW

Healthcare
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a... see more

Recent & Breaking News (OTCPK:AGRX)

Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference

GlobeNewswire May 17, 2022

Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update

GlobeNewswire May 12, 2022

Agile Therapeutics Announces Findings of First-Year Post-Marketing Pharmacovigilance in ACOG Poster Presentation

GlobeNewswire May 5, 2022

Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022

GlobeNewswire May 3, 2022

Agile Therapeutics Announces 1-For-40 Reverse Stock Split

GlobeNewswire April 26, 2022

Agile Therapeutics Announces First Quarter 2022 Prescription Data for Twirla®

GlobeNewswire April 14, 2022

Agile Therapeutics Receives $4.7M After Selling Net Operating Loss Tax Benefits Through New Jersey Economic Development Program

GlobeNewswire April 11, 2022

Agile Therapeutics® Announces Poster Presentation at the 2022 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG)

GlobeNewswire April 7, 2022

Agile Therapeutics® Announces First Twirla® Commercial Targeting Gen Z

GlobeNewswire March 31, 2022

Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update

GlobeNewswire March 30, 2022

Agile Therapeutics Announces Closing of $4.85 Million Registered Direct Offering

GlobeNewswire March 14, 2022

Agile Therapeutics Announces $4.85 Million Registered Direct Offering

GlobeNewswire March 14, 2022

Agile Therapeutics to Participate in Upcoming March Investor Events

GlobeNewswire March 11, 2022

Agile Therapeutics to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Wednesday, March 30, 2022

GlobeNewswire March 7, 2022

Agile Therapeutics Acknowledges New Government Guidance Reinforcing Requirement to Cover Contraceptives that a Woman and Her Heathcare Provider Determine are Medically Appropriate at No Cost

GlobeNewswire January 12, 2022

Agile Therapeutics and Afaxys Partner to Expand Access to Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System

GlobeNewswire January 10, 2022

Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 5, 2022

Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences

GlobeNewswire January 5, 2022

Agile Therapeutics Reports Third Quarter 2021 Financial Results

GlobeNewswire November 2, 2021

Agile Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on Tuesday, November 2, 2021

GlobeNewswire October 22, 2021